How to Read a Peptide Certificate of Analysis

A Certificate of Analysis (CoA) is the single most important quality document for any research peptide. It provides analytical proof that the compound you received is what it claims to be, at the purity it claims to have. Understanding how to read and evaluate a CoA is an essential research skill that separates rigorous investigators from those working with unverified materials.

Anatomy of a Research Peptide CoA

A complete CoA for a research-grade peptide should contain the following sections:

Section	What It Shows	Why It Matters
Product identification	Peptide name, sequence, molecular formula	Confirms the correct compound
Batch/lot number	Unique identifier for this production run	Links the CoA to YOUR specific product
HPLC purity	Percentage purity with chromatogram	Quantifies impurity levels
Mass spectrometry	Observed vs expected molecular weight	Confirms molecular identity
Appearance	Physical description (color, form)	Visual quality indicator
Solubility	Dissolution behavior in specified solvents	Handling verification
Net peptide content	Active peptide percentage by weight	Actual peptide vs salt/water content
Endotoxin (optional)	LAL test results	Bacterial contamination check

HPLC Purity: The Core Metric

High-Performance Liquid Chromatography (HPLC) is the gold standard for peptide purity assessment. The technique separates the peptide mixture into its components based on hydrophobicity, then measures the relative abundance of each component via UV absorbance (typically at 220 nm for peptide bond detection).

Reading the Chromatogram

The HPLC chromatogram is the single most informative element of a CoA. A high-quality chromatogram shows:

• Dominant single peak: The target peptide should appear as one large, sharp, symmetric peak
• Clean baseline: The baseline between peaks should be flat and stable, indicating good chromatographic resolution
• Small impurity peaks: Minor peaks represent synthesis byproducts, deletion sequences, or degradation products. These should be small and well-separated from the main peak
• Retention time: The main peak should elute at a retention time consistent with the peptide's hydrophobicity

For a deeper understanding of what purity percentages actually mean for your research, see our article on what 98% purity actually represents.

Mass Spectrometry: Identity Confirmation

Mass spectrometry (MS) provides molecular weight confirmation. The two most common techniques for peptide CoAs are:

Technique	Accuracy	Best For	CoA Display
ESI-MS	±0.01-0.1 Da	Small-medium peptides	Multiple charge state peaks
MALDI-TOF	±0.1-1.0 Da	Larger peptides/proteins	Single [M+H]+ peak

The observed mass should match the theoretical mass (calculated from the amino acid sequence) within the instrument's accuracy. A match of ±1 Da or less for ESI-MS is typically acceptable. Discrepancies of 18 Da suggest dehydration, 16 Da suggests oxidation, and multiples of amino acid residue masses suggest deletion or insertion errors.

Net Peptide Content vs Gross Weight

This is one of the most misunderstood aspects of peptide CoAs. A vial labeled "5 mg" contains 5 mg of gross powder, but not all of that is active peptide. The gross weight includes:

• Active peptide: The target compound (typically 60-85% of gross weight)
• Counterions: TFA or acetate salts from synthesis/purification
• Water: Residual moisture, even in lyophilized form (typically 2-8%)

The net peptide content (NPC) tells you the actual percentage of active peptide. A vial of 5 mg gross weight with 70% NPC contains 3.5 mg of actual peptide. This has direct implications for dosing accuracy in quantitative research.

Red Flags: What Makes a CoA Unreliable

• No batch/lot number: Cannot be linked to your specific product
• No chromatogram: A purity number without the chromatogram is unverifiable
• Round numbers only: Real analytical data produces values like 98.7% or 99.23%, not exactly 99.0%
• Missing MS data: No molecular weight confirmation means no identity verification
• Identical CoAs across batches: Every batch should produce unique analytical data
• No lab name or analyst: Legitimate testing facilities identify themselves

For guidance on evaluating suppliers based on their CoA practices, see our supplier selection guide.

Third-Party vs In-House Testing

In-house CoAs come from the manufacturer's own laboratory. While these provide baseline quality data, they carry an inherent conflict of interest. Third-party CoAs from independent laboratories (such as Janssen, Eurofins, or university analytical facilities) provide unbiased verification. The most transparent suppliers provide both.

Key Research Context

Understanding the research context for How to Read a Peptide Certificate of Analysis requires consideration of multiple factors including compound purity, experimental design, appropriate controls, and reproducibility standards. The scientific literature provides a foundation for evaluating the biological activity and potential applications of this compound category.

Research-grade compounds require rigorous quality verification before use in any experimental protocol. This includes confirming identity via mass spectrometry, verifying purity via HPLC chromatography (targeting ≥98% for definitive studies), and ensuring proper storage conditions have been maintained throughout the supply chain. A validated Certificate of Analysis from the supplier, ideally with third-party verification, is the minimum standard for quality assurance.

Experimental Design Considerations

Researchers should consider several practical factors when designing experiments with this compound. Dose-response curves should be established using at least three concentration points spanning the expected effective range. Vehicle controls must match the reconstitution buffer exactly. Time-course experiments help determine optimal treatment duration and peak effect windows. For in vivo studies, route of administration significantly affects bioavailability and tissue distribution patterns.

Proper reconstitution technique is essential for accurate dosing. Always inject diluent slowly along the vial wall rather than directly onto the lyophilized cake. Gentle swirling (never vortexing or shaking) prevents aggregation and denaturation. Use bacteriostatic water for multi-dose vials and sterile water for single-use preparations. Record the reconstitution date, concentration, and storage conditions for each vial.

Literature and Evidence Standards

When evaluating the research evidence for any peptide compound, consider the hierarchy of evidence: randomized controlled clinical trials provide the strongest evidence, followed by controlled preclinical studies in validated animal models, then in vitro cell culture studies, and finally computational or theoretical analyses. The number of independent research groups replicating findings, publication in peer-reviewed journals, and consistency of results across different experimental systems all contribute to the overall evidence quality assessment.

Researchers should also be aware of publication bias (positive results are more likely to be published than negative results) and the importance of proper statistical analysis in interpreting study outcomes. Effect sizes, confidence intervals, and appropriate statistical tests are as important as p-values in evaluating research significance. For a comprehensive understanding of peptide quality metrics, review our guide on what 98% purity means and how to interpret analytical data from qualified suppliers.

Methodological Framework

Rigorous research methodology is essential for generating reliable data with any research compound. The following framework outlines best practices for experimental design, quality control, and data interpretation that apply to studies involving this compound category.

Quality Control Protocol

Before initiating any experimental protocol, verify the compound identity and purity through independent analytical testing. The minimum verification standard includes reversed-phase HPLC analysis confirming ≥98% purity and mass spectrometry confirming the correct molecular weight within ±1 Da of the theoretical value. For compounds with disulfide bonds or metal coordination (such as copper peptides), additional analytical methods may be required to confirm proper folding or complexation. Document the lot number, vendor, CoA reference, and storage conditions for every compound used in research.

Dose-Response Characterization

Establishing a complete dose-response curve is fundamental to characterizing any bioactive compound. Use a minimum of five concentration points spanning at least two logarithmic orders of magnitude. Include both sub-threshold and supra-maximal concentrations to define the full response range. Calculate EC50 (half-maximal effective concentration) values using nonlinear regression with appropriate curve-fitting models. For in vivo studies, allometric scaling from published animal data provides initial dose estimates, but species-specific pharmacokinetic differences necessitate empirical dose optimization.

Controls and Replication

Every experiment requires appropriate controls: vehicle controls (matching the reconstitution buffer composition exactly), positive controls (a compound with known activity in the assay system), and negative controls (untreated or inactive analog). Biological replicates (independent experiments on different days with different cell passages or animal cohorts) are more informative than technical replicates (repeated measurements of the same sample). A minimum of three biological replicates is standard for publication-quality data. Statistical analysis should include measures of central tendency, variability (standard deviation or standard error), and appropriate hypothesis testing with correction for multiple comparisons where applicable.

Safety and Handling

All research compounds should be handled according to standard laboratory safety protocols. Wear appropriate personal protective equipment (gloves, lab coat, eye protection) when handling lyophilized powders and reconstituted solutions. Avoid inhalation of lyophilized powder during reconstitution. Dispose of unused compound and contaminated materials according to institutional biosafety and chemical waste guidelines. Research peptides are intended for laboratory research use only and are not approved for human therapeutic use unless specifically noted (such as FDA-approved compounds like Tesamorelin).

Proper storage extends compound viability and ensures consistent experimental results. Lyophilized compounds should be stored at -20°C with desiccant in sealed containers. After reconstitution with bacteriostatic water, store at 2-8°C and use within the validated stability window (typically 3-4 weeks). For long-term storage of reconstituted solutions, prepare single-use aliquots and freeze at -20°C to avoid repeated freeze-thaw cycles that accelerate degradation.

Frequently Asked Questions

What is a Certificate of Analysis?

A CoA is an analytical document reporting testing results for a specific batch of product, including HPLC purity, mass spectrometry identity confirmation, and physical characterization data.

What purity should research peptides have?

Research-grade peptides should be 95% or higher by HPLC. Premium research-grade is 98%+. For quantitative research where impurities could confound results, 99%+ is preferred.

FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. This article is intended for educational and informational purposes only. It does not constitute medical advice. Last updated: April 20, 2026.